Evaluation of the Mechanism of Modified Lingguizhugan Decoction in the Treatment of Nonalcoholic Fatty Liver Disease

<div>MLGZG ameliorates NASH in an HFD NASH rat model. Photographs of H&amp;E-stained paraffin sections of livers from rats treated with saline or MLGZG (100×) (black arrow indicated hepatocyte vacuolization; HFD: high-fat diet; MLGZG<sup>L</sup>: MLGZG low dose; MLGZG<sup>M</sup>: MLGZG moderate dose; MLGZG<sup>H</sup>: MLGZG high dose).</div>

Evidence-Based Complementary and Alternative Medicine

fig2

Figure 2

Figure 2: Evaluation of the Mechanism of Modified Lingguizhugan Decoction in the Treatment of Nonalcoholic Fatty Liver Disease 